129 related articles for article (PubMed ID: 15619212)
21. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
Hwang RF; Gonzalez-Angulo AM; Yi M; Buchholz TA; Meric-Bernstam F; Kuerer HM; Babiera GV; Tereffe W; Liu DD; Hunt KK
Cancer; 2007 Aug; 110(4):723-30. PubMed ID: 17587208
[TBL] [Abstract][Full Text] [Related]
22. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
23. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Mamtani A; Barrio AV; King TA; Van Zee KJ; Plitas G; Pilewskie M; El-Tamer M; Gemignani ML; Heerdt AS; Sclafani LM; Sacchini V; Cody HS; Patil S; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3467-3474. PubMed ID: 27160528
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
[TBL] [Abstract][Full Text] [Related]
25. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
26. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
[TBL] [Abstract][Full Text] [Related]
27. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.
Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A
Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227
[TBL] [Abstract][Full Text] [Related]
28. Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer.
Takei H; Kurosumi M; Yoshida T; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Asakawa H; Oba H; Inoue K; Tabei T
Breast; 2009 Aug; 18(4):244-7. PubMed ID: 19559610
[TBL] [Abstract][Full Text] [Related]
29. Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age.
Orucevic A; Reddy VB; Bloom KJ; Bitterman P; Magi-Galluzzi C; Oleske DM; Phillips M; Gould VE; Cobleigh M; Wick MR; Gattuso P
Breast J; 2002; 8(6):349-55. PubMed ID: 12390357
[TBL] [Abstract][Full Text] [Related]
30. Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.
Umekita Y; Ohi Y; Iwaya O; Souda M; Sagara Y; Tamada S; Yotsumoto D; Tanimoto A
Histopathology; 2018 Dec; 73(6):916-922. PubMed ID: 30035819
[TBL] [Abstract][Full Text] [Related]
31. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
32. Axillary sentinel lymph node micrometastases with extracapsular extension: a distinct pattern of breast cancer metastasis?
Cserni G
J Clin Pathol; 2008 Jan; 61(1):115-8. PubMed ID: 17468292
[TBL] [Abstract][Full Text] [Related]
33. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
Boler DE; Uras C; Ince U; Cabioglu N
Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
[TBL] [Abstract][Full Text] [Related]
34. Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.
Kim WG; Lee J
Int J Surg Pathol; 2017 Aug; 25(5):397-405. PubMed ID: 28145149
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
Abd El-Rehim D; Ali MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
37. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
38. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
39. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
40. Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.
Montemurro F; Maggiorotto F; Valabrega G; Kubatzki F; Rossi V; Magistris A; Marocco F; Gatti M; Sarotto I; Aglietta M; Ponzone R
Ann Surg Oncol; 2012 Nov; 19(12):3755-61. PubMed ID: 22805871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
